These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19412491)

  • 1. The Smart Drug Delivery of Rotigotine Using Transdermal Patch for the Successful Management of Parkinson's Disease.
    Dharmian JP; PushpaNathan ACS; Ramakrishnan P; Subramanian RN; Levy JD; Palani P; Krishnaswami V
    Cent Nerv Syst Agents Med Chem; 2024 Jun; ():. PubMed ID: 38910418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch.
    Li Y; Wang J; Vora LK; Sabri AHB; McGuckin MB; Paredes AJ; Donnelly RF
    J Control Release; 2024 Jun; 372():304-317. PubMed ID: 38906420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless Legs Syndrome and Impulse Control Disorders in Patients with Parkinson's Disease: An Intricate Association.
    Yadav R
    Ann Indian Acad Neurol; 2024; 27(1):1-2. PubMed ID: 38495250
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of rasagiline on swallowing function in Parkinson's disease.
    Hirano M; Samukawa M; Isono C; Kusunoki S; Nagai Y
    Heliyon; 2024 Jan; 10(1):e23407. PubMed ID: 38187336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of safinamide on dysphagia in Parkinson's disease.
    Hirano M; Samukawa M; Isono C; Nagai Y
    PLoS One; 2023; 18(5):e0286066. PubMed ID: 37228084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.
    Jin W
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of dopamine D₃ receptor neurotransmission in cognition.
    Nakajima S; Gerretsen P; Takeuchi H; Caravaggio F; Chow T; Le Foll B; Mulsant B; Pollock B; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):799-813. PubMed ID: 23791072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal patches for the treatment of neurologic conditions in elderly patients: a review.
    Farlow MR; Somogyi M
    Prim Care Companion CNS Disord; 2011; 13(6):. PubMed ID: 22454804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless legs is a medical disorder and can be treated.
    Pinder RM
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):391-2. PubMed ID: 19412488
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathological gambling and dopamine agonists: A phenotype?
    Pinder RM
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):1-2. PubMed ID: 19300534
    [No Abstract]   [Full Text] [Related]  

  • 11. Rotigotine transdermal patch: in restless legs syndrome.
    Baldwin CM; Keating GM
    CNS Drugs; 2008; 22(10):797-806. PubMed ID: 18788832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.
    Boroojerdi B; Wolff HM; Braun M; Scheller DK
    Drugs Today (Barc); 2010 Jul; 46(7):483-505. PubMed ID: 20683503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
    Splinter MY
    Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.
    Garnock-Jones KP
    Drugs; 2016 Jul; 76(10):1031-40. PubMed ID: 27324269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.
    Baldwin CM; Keating GM
    CNS Drugs; 2007; 21(12):1039-55. PubMed ID: 18020483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotigotine transdermal system: a short review.
    Bunten S; Happe S
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):421-6. PubMed ID: 19412491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
    Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
    Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.